Literature DB >> 3514810

High-dose melphalan and autologous bone marrow transplant as treatment for refractory Hodgkin's disease.

P J Selby, E K Mbidde, J Maitland, T J McElwain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3514810

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Ondansetron--a new safe and effective antiemetic in patients receiving high-dose melphalan.

Authors:  C V Viner; P J Selby; G B Zulian; M E Gore; M E Butcher; C M Wootton; T J McElwain
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.